Dr. Agarwal’s Health Care Limited has disclosed the receipt of a Show Cause Notice from the GST authorities regarding the 2023-24 financial year. The notice alleges tax discrepancies totaling Rs. 20.50 Crores, covering areas such as output turnover, input tax credit, and e-invoicing compliance. The company is currently reviewing the notice and plans to file a formal response within the prescribed 30-day window, maintaining that there is no expected material impact on its operations.
Details of the Tax Notice
The company received a Show Cause Notice dated May 18, 2026, from the Office of the Assistant Commissioner, GST & Central Excise. The communication highlights several areas of concern related to the 2023-24 financial year, including discrepancies in output turnover, short payment of tax under the Reverse Charge Mechanism (RCM), and issues surrounding the claim of input tax credits.
Financial and Operational Outlook
The total amount in question, including applicable interest and penalties, is Rs. 20.50 Crores. The organization has stated that it is actively examining the details provided in the notice to prepare a comprehensive reply for the authorities. At this stage, the company does not anticipate any significant impact on its overall financial health, ongoing operations, or business activities as a result of this development.
Management Response and Timeline
The company acknowledged that the disclosure was delayed due to the notice being sent to a centralized email address that experiences high volumes of automated notifications. Upon discovering the notice, management acted promptly to evaluate the technical and financial implications. The company is committed to addressing the queries raised by the tax department and intends to submit its response within the mandatory 30-day period.
Source: BSE
